Trexquant Investment’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-251,299
| Closed | -$2.09M | – | 1749 |
|
|
2024
Q3 | $2.09M | Sell |
251,299
-404,248
| -62% | -$3.36M | 0.03% | 793 |
|
|
2024
Q2 | $4.69M | Buy |
655,547
+223,998
| +52% | +$1.6M | 0.07% | 424 |
|
|
2024
Q1 | $3.74M | Buy |
+431,549
| New | +$3.74M | 0.07% | 412 |
|
|
2023
Q2 | – | Sell |
-108,458
| Closed | -$1.52M | – | 1660 |
|
|
2023
Q1 | $1.52M | Buy |
+108,458
| New | +$1.52M | 0.04% | 562 |
|
|
2022
Q2 | – | Sell |
-23,548
| Closed | -$831K | – | 1732 |
|
|
2022
Q1 | $831K | Sell |
23,548
-132,620
| -85% | -$4.68M | 0.04% | 549 |
|
|
2021
Q4 | $6.54M | Buy |
+156,168
| New | +$6.54M | 0.4% | 41 |
|
|
2021
Q3 | – | Sell |
-19,511
| Closed | -$814K | – | 1359 |
|
|
2021
Q2 | $814K | Buy |
+19,511
| New | +$814K | 0.07% | 356 |
|